Company Profile

🩺 Arvo

Automated medical-claim validation.

🩺 Health AIBrazilSeries A

Quick facts

Country
Brazil
Sector
Health AI
Latest disclosed round
Series A
Amount
US$20M
Backers
Kaszek, Base10
Reviewed

About

Backed by Kaszek, Base10, as publicly reported.

What "Series A" means

the first fully institutional round, raised once a company has a working business model and is scaling it — typically led by a venture fund writing a meaningfully larger cheque than seed investors. Failure rates drop from here, but are still substantial.

Why health ai is attracting capital

Health and biotech is one of the busiest early-stage categories across Latin America right now, spanning AI-assisted diagnostics, telehealth and admin automation for clinics — all sectors where regulatory approval and clinical validation, not just software, become the real bottleneck to scale.

Before you read anything into this

Arvo is not investable by the general public — this round was private, and nothing on this page is a recommendation, a rating or a prediction. Inclusion on our early-stage watchlist means a credible public source reported this round with a named stage; we have not done diligence on the company and have no view on its prospects. Most early-stage startups fail.

Understand the actual routes into deals like this one:
How to invest in startups →

← All startups on the watchlist

Frequently asked questions

Can I invest directly in Arvo?
Almost certainly not. Arvo raised this round privately from venture investors, not the public. The realistic routes into early-stage deals generally are regulated equity crowdfunding, a syndicate, or a venture fund — see our guide to the four routes.
What does "Series A" mean?
the first fully institutional round, raised once a company has a working business model and is scaling it — typically led by a venture fund writing a meaningfully larger cheque than seed investors. Failure rates drop from here, but are still substantial.
Does appearing on this list mean Arvo is a good investment?
No. Inclusion means a credible source reported a recent early-stage round, nothing more. We have not done diligence on this company, and the base rate for early-stage startups is failure.
Where does this information come from?
Compiled from public reporting as part of our early-stage watchlist, which lists the review date and full sources. Funding stages change quickly — check the company's own site or a deal database before relying on any detail here.